DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

Medical charities do measurable good in the world A look at some organizations bringing goods and services where they are needed most

Merit Medical Systems closes acquisition of Cianna Medical Deal worth $135 million with possible additional incentivized payments

Mike Lobinsky EOS Imaging appoints new President North America

Daniel Kelsey AHRA hires chief executive officer

Clinical wearables – remaining competitive in an evolving market Insights from Ravi Kuppuraj, Business Leader of Connected Sensing Venture for Philips

TIAA Bank acquires $1.5 billion portfolio from GE Capital's HEF business Portfolio of healthcare equipment leases and loans

Driving premium platform valuations for future growth The radiology M&A market is red hot, help investors see the value in your business

Robert Sledd Owens & Minor names board member, chairman and interim president and CEO

Veritas Capital, Evergreen Coast Capital to take athenahealth for $5.7 billion Gives athenahealth stock holders $135 in cash per share

A look into the medical device design process Go behind the scenes to see what factors contribute to the design of new medical devices

Does GE CEO move cast doubt on healthcare spinoff?

Thomas Dworetzky , Contributing Reporter
Industry watchers have started to weigh in on the impact of the sudden replacement of GE CEO John Flannery with H. Lawrence Culp Jr. – and CNBC's Jim Cramer thinks the new CEO will put “everything on the table.”

“Everything on the table means I don't necessarily think he's going to give away [GE Healthcare] because he understood how great that healthcare division is,” Cramer said on Monday's “Squawk on the Street”.

Story Continues Below Advertisement

RamSoft PowerServer™ RIS/PACS - Enabling Efficient Diagnostic Imaging

RamSoft's PowerServer™ RIS/PACS is an intuitive, single database application that enables healthcare practices to operate diagnostic imaging more efficiently than ever before.Why is this important? Click to find out.



Another industry watcher, CFRA research analyst Jim Corridore, told Monday's Power Lunch that Culp could change his mind and keep healthcare with the company.

“Maybe healthcare is not going to get spun off now,” he suggested, noting that, “maybe some of the parts that were going to be sold make more sense today.”

But GE Healthcare spokeswoman Jennifer Fox told the news channel that the CEO switch does not change the unit's fate. “Plans to continue working toward separation … [do] not change what's happening at GE Healthcare.” The company underscored that it is still “committed to establishing healthcare as a separate independent entity.”

One reason that keeping the unit might be tempting is that it is a cash machine, putting around $19 billion in revenue and $3.4 billion in profit toward GE's bottom line – translating to 15.8 percent of the conglomerate's total sales, and 43.2 percent of its operating profit in 2017, according to CNBC.

Not all watchers think the spinoff is wobbly, however. Scott Davis, chairman and CEO of Melius Research is one who thinks that the CEO shuffle won't alter the course for GE Healthcare. “But I suppose anything is possible,” he noted to the business news channel.

The brevity of Flannery's run is remarkable for the storied company, whose previous CEOs had much longer tenures.

“This is somewhat remarkable because John Flannery just started," Cramer noted, admitting that, “I do feel bad for John. He was trying to deal with the hand that Jeff Immelt left him. The hand was too hard.”

Over a 16-year span Immelt's leadership had led the massive company to a 38 percent loss of value.

Sources have said that problems, revealed Sept. 20th, with its latest line of natural gas-powered turbines were not the issue, according to CNBC's Andrew Ross Sorkin. “The board was unsatisfied with the execution that was taking place under John Flannery's leadership,” he said, adding that its frustration “hardened over the last several weeks,” in response “to the slow pace of change.”
  Pages: 1 - 2 >>

Business Affairs Homepage


(13)

(1)

Wayne Webster

Compnsation

October 05, 2018 09:10

Mr. Culp's earnings are remarkably impacted by his ability to raise the price of the stock. That will be his focus.

Log inor Register

to rate and post a comment

You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2018 DOTmed.com, Inc.
版权所有